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Abstract
• Scleroderma limits individuals in normal activities of daily living
• Occupational therapy is recommended for individuals with
scleroderma within the first few years of the disease
• Studies have shown that occupational therapy is effective in
individuals with scleroderma
• Scleroderma or systemic sclerosis is a complex polygenetic
disease that has 2 subtypes:
• Limited
Affects individuals' muscles and how they functions
• Diffuse
Affects individuals’ internal organs (Shah, 2013)
• The purpose of this study is to determine the effects of
occupational therapy in damaged hand muscles of females
with scleroderma

Introduction and Objectives
• More than 300,000 Americans live with some type of
scleroderma (National Scleroderma Foundation)
• Scleroderma typically effects the female population
• There is approximately 1 in 10,000 female individuals affected
by Scleroderma and about 1 man per every 3 to 4 women
affected (Peoples et. al, 2016)
• Scleroderma is characterized by Raynaud phenomenon
• Raynaud phenomenon is when some areas of the body can
sense hot and cold when stimulated and is accompanied by
changes of skin color (Shah, 2013)
• There is currently no cure for Scleroderma
• It takes years to diagnosis an individual with Scleroderma due
to how rare the disease is
• Symptoms include:
• Fatigue
• Weight loss
• Musculoskeletal pain
• Gastrointestinal reflux
• Nailfold capillary change
• Edema (Shah, 2013)
• Participants will go through 6 months of occupational therapy
with 4 assessments spread throughout that time period
• The goal of this study is for participants hand muscles to
become stronger after going through therapy and for them to
be able to perform normal activities of daily living with less
pain

Methodology

Operational Definitions

• Gather participants by reaching out to the National Scleroderma Foundation to find
16 females who are willing to complete the study who are within a 30-mile radius
of Shelby, NC
• Gather all participants information by emailing them the following information: the
PAR-Q, medical history questionnaire, questionnaires related to how well they can
perform normal activities of daily living
• Next the participants will go through the initial assessment evaluation
• After all participants complete the initial assessment, they will start occupational
therapy
• Each participant will complete therapy 3 days/week for a 6-month period
• During the 6-month period the participants will complete 2 midterm assessments
to determine how much they have improved since the start of the study
• Following the 6-month period the participants will go through a final assessment
and complete the initial questionnaire asking how well they can perform normal
activities of daily living
• Data will be kept for each participant in separate digital files

• Scleroderma: also known as systemic sclerosis is a
chronic connective tissue disease generally classified as
an autoimmune disease. The word scleroderma comes
from the Greek word ”sclero” meaning hard and the Latin
word “derma” meaning skin. Hardening of the skin is one
of the most visible manifestations of the disease. The
disease varies from individual to individual and the
disease is not contagious (National Scleroderma
Foundation, 2022)
• Occupational Therapy: An allied health professional that
involves the therapeutic use of everyday activities to
treat the physical, mental, developmental, and emotional
aliments that impact a patient's ability to perform day to
day tasks (Regis College)
• Diffuse Scleroderma: skin thickening occurs more rapidly
and involves more skin areas than limited (National
Scleroderma Foundation)
• Limited Scleroderma: skin thickening is less widespread,
typically confined to the fingers, hands, and face, and
develops slowly over years (National Scleroderma
Foundation

Conclusion
• In testing the hypothesis, it was assumed that each client
completed the therapy as instructed and that they answered
all questionnaires honestly
• Further research can be conducted with larger sample sizes
and male participants
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